24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
PhaseV
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:42
“An excellent thing”: Why some Finance Ministry officials welcome the end of U.S. aid
18:34
Israel has spent years preparing to end U.S. military aid. Now the bill is coming due
15:00
Apple faces an uncomfortable choice: Raise prices or sacrifice its famously high margins
14:47
Teva’s transformation gains momentum as innovative drug sales rise 33%
More stories
Buzz
Most popular
Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Israeli digital health company TailorMed acquired in $250 million deal
4
After years of delays, IDF prepares to deploy Elbit’s new Ro'em artillery systems
5
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
More news
PhaseV
4 stories about PhaseV
WATCH: CTech's most promising healthtech startups
29.05.25
|
CTech
Here's everything you need to know about Sensi.ai, Briya Labs, PhaseV, Zorro, and DeepCure
PhaseV raises $50 million Series A to rethink how drugs get to market
13.05.25
|
CTech
With over 30 global customers, the AI startup targets inefficiencies in clinical trials.
Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development
27.03.25
|
James Spiro
CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York.
PhaseV raises $15 million to optimize clinical trials with causal machine learning
24.10.23
|
CTech
The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps